首页> 外国专利> New unsaturated fatty amino acid derivatives useful e.g. to prepare dermocosmetologic antiradical, anti-inflammatory, anti-pruritic or anticollagenase compositions and to treat skin aging, keratinization and pigmentation disorders

New unsaturated fatty amino acid derivatives useful e.g. to prepare dermocosmetologic antiradical, anti-inflammatory, anti-pruritic or anticollagenase compositions and to treat skin aging, keratinization and pigmentation disorders

机译:有用的新的不饱和脂肪酸氨基酸衍生物例如制备皮肤科抗自由基,抗炎,止痒或抗胶原酶组合物,并治疗皮肤老化,角质化和色素沉着症

摘要

Unsaturated fatty amino acid derivatives (I) and their acid addition salts, as drugs, are new. Unsaturated fatty amino acid derivatives of formula (R a)(R b)N-CH 2-(CH(R n)) n-CH=C(R 1)-C(O)-OR (I) and their acid addition salts, as drugs, are new. X : O or NH; R nH or 1-6C alkyl (optionally substituted by halo), preferably H; R 1H, F, Cl or Br, CF 3, CHF 2 or 1-6C alkyl, 1-6C alkenyl or 1-6C alkynyl (optionally substituted by halo), preferably H or F; R : H, 1-6C alkyl or 3-6C cycloalkyl (optionally substituted by halo), preferably H; R a, R bH, 1-6C alkyl or 1-6C acyl, preferably H, or 4-6C hydrocarbon ring; and n : 2-14, preferably 3. Provided that as a new compound (I) is excluded from 6-amino-hex-2-enoic acid, its hydrochloride and trifluoroacetate, 8-amino-oct-2-enoic acid trifluoroacetate, 8-(dimethylamino)-oct-2-enoic acid, 12-(dimethylamino)-dodec-2-enoic acid, 6-(isopropylamino)-2-methyl-hex-2-enoate, ethyl-6-(tert-butylamino)-2-methyl-hex-2-enoate, 6-amino-2-methyl-hex-2-enoate, 7-amino-hept-2-enoate, 7-amino-2-methyl-hept-2-enoate and 7-amino-4-methyl-hept-2-enoate. Independent claims are included for: (1) the preparation of (I); and (2) an ester compound of formula PG-N(R d)-CH 2-(CHR 1)-C(O)-OR c (VIII). R cH or 1-6C alkyl; R 1H, F, Cl, Br, -CF 3 or -CHF 2, or 1-6C alkyl, alkenyl or alkynyl (optionally substituted by halo, preferably F); PG : a protecting group forming a carbamate group, preferably tert. butyl carbamate or benzyl carbamate, and R dH or PG, provided that (VIII) is excluded from tert-butyl-(E)-6-(N,N-di-tert-butoxycarbonylamino)-hex-2-tert-enoate, ethyl (E)-6-(N-tert-butoxy-carbonylamino)-hex-2-enoate, methyl-(E)-7-(E-tert-butoxy-carbonylamino)-hept-2-enoate and (E)-7-(E-tert-butoxy-carbonylamino)-hept-2-enoic acid. ACTIVITY : Dermatological; Antiinflammatory; Antipruritic; Vulnerary. MECHANISM OF ACTION : Melanogenesis modulator.
机译:作为药物的不饱和脂肪酸氨基酸衍生物(I)及其酸加成盐是新的。式(R a)(R b)N-CH 2-(CH(R n))n-CH = C(R 1)-C(O)-OR(I)的不饱和脂肪酸氨基酸衍生物及其酸加成作为药物的盐是新的。 X:O或NH; R nH或1-6C烷基(任选地被卤素取代),优选为H; R 1H,F,Cl或Br,CF 3,CHF 2或1-6C烷基,1-6C烯基或1-6C炔基(可选被卤素取代),优选H或F; R:H,1-6C烷基或3-6C环烷基(任选被卤素取代),优选为H; R a,R bH,1-6C烷基或1-6C酰基,优选为H或4-6C烃环; n为2-14,优选为3。条件是作为新化合物(I)从6-氨基-己-2-烯酸,其盐酸盐和三氟乙酸盐,8-氨基-辛-2-烯酸三氟乙酸盐中排除, 8-(二甲基氨基)-辛-2-烯酸,12-(二甲基氨基)-十二烷基-烯酸,6-(异丙氨基)-2-甲基-己-2-烯酸酯,乙基-6-(叔丁基氨基) )-2-甲基-己-2-烯酸酯,6-氨基-2-甲基-己-2-烯酸酯,7-氨基庚-2-烯酸酯,7-氨基-2-甲基庚-2-烯酸酯和7-氨基-4-甲基-庚-2-烯酸酯。独立索赔包括:(1)(I)的制备; (2)式PG-N(R d)-CH 2-(CHR 1)-C(O)-OR c(VIII)的酯化合物。 R cH或1-6C烷基; R 1H,F,Cl,Br,-CF 3或-CHF 2或1-6C烷基,烯基或炔基(可选地被卤素取代,优选为F); PG:形成氨基甲酸酯基的保护基,优选叔。氨基甲酸丁酯或氨基甲酸苄酯,以及R dH或PG,前提是(VIII)不包括在叔丁基-(E)-6-(N,N-二叔丁氧羰基氨基)-己-2-叔烯酸酯中(E)-6-(N-叔丁氧基-羰基氨基)-2-烯酸乙酯,(-E)-7-(E-叔丁氧基-羰基氨基)-庚-2-烯酸酯和(E) -7-(E-叔丁氧基-羰基氨基)-庚-2-烯酸。活动:皮肤科;消炎(药;止痒;伤药。作用机理:黑色素生成调节剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号